| 注册
首页|期刊导航|中国临床医学|促性腺激素释放激素拮抗剂方案与激动剂长方案应用于新鲜胚胎移植患者的疗效比较

促性腺激素释放激素拮抗剂方案与激动剂长方案应用于新鲜胚胎移植患者的疗效比较

陈军玲 刘素英 李路 陈国武 张璇 孙晓溪

中国临床医学2017,Vol.24Issue(3):339-342,4.
中国临床医学2017,Vol.24Issue(3):339-342,4.DOI:10.12025/j.issn.1008-6358.2017.20170065

促性腺激素释放激素拮抗剂方案与激动剂长方案应用于新鲜胚胎移植患者的疗效比较

Efficacy comparison of GnRH antagonist protocol and GnRH long protocol for the patients undergoing fresh embryo transfer

陈军玲 1刘素英 2李路 1陈国武 1张璇 3孙晓溪1

作者信息

  • 1. 复旦大学附属妇产科医院上海集爱遗传与不育诊疗中心,上海 200011
  • 2. 复旦大学附属中山医院生殖医学中心,上海 200032
  • 3. 上海市计划生育科学研究所,上海 200032
  • 折叠

摘要

Abstract

Objective:To compare the clinical effect between gonadotrophin-releasing hormone (GnRH) antagonist protocol and GnRH agonist long protocol in patients obtaining fresh embryo transfer.Methods:Clinical data of patients in the fresh embryo transfer cycle were analyzed retrospectively.Main clinical outcomes including superovulation and pregnant rates were compared.Results:A total of 706 cases were selected, 637 patients received GnRH agonist long protocol, and 69 patients received antagonist protocol.Compared with agonist group, the patients in antagonist group had significantly shorter duration of gonadotropin ([10.55±1.38] d vs [11.20±1.84] d), fewer doses ([1 699.50±611.25] U vs [2 196.75±765.75] U, P<0.05), more oocytes (12.11±5.20 vs 9.69±3.86, P<0.05), and more MⅡoocytes (10.15±4.65 vs 8.26±3.50, P<0.05).However, there was no significant difference in thickness of endometrium, fertilization rate, implantation rate, and pregnant rate between the two groups.Conclusions:Compared with the long GnRH agonist protocol, the GnRH antagonist protocol can bring out a substantial increase in the number of good quality embryos among the patients receiving fresh embryo transfer, but shows no advantage in pregnant rate.

关键词

胚胎移植/妊娠率/GnRH拮抗剂/GnRH激动剂

Key words

embryo transfer/pregnant rate/GnRH antagonist/GnRH agonist

分类

医药卫生

引用本文复制引用

陈军玲,刘素英,李路,陈国武,张璇,孙晓溪..促性腺激素释放激素拮抗剂方案与激动剂长方案应用于新鲜胚胎移植患者的疗效比较[J].中国临床医学,2017,24(3):339-342,4.

基金项目

上海市卫生与计划生育委员会课题基金(20134146).Supported by Foundation of Shanghai Municipal Health and Family Planning Commission (20134146). (20134146)

中国临床医学

OACSTPCD

1008-6358

访问量0
|
下载量0
段落导航相关论文